about
Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort studyPsoriasis genetics: breaking the barrierBurden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian PerspectiveCo-morbidity in psoriasis: mechanisms and implications for treatment.Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms.Impact of metabolic status on the incidence of psoriasis: a Korean nationwide cohort studyAre ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies.Assessing long-term drug safety: lessons (re) learned from raptiva.Psoriasis and cardiovascular risk: strength in numbersDiet and weight loss as a treatment for psoriasis.Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasisCause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.Hypertension, antihypertensive medication use, and risk of psoriasis.Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion.Initiation of TNF inhibitor therapy and change in physiologic measures in psoriasis.Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies.Prognosis after percutaneous coronary intervention in patients with psoriasis: a cohort study using Danish nationwide registries.Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities.Validity of The Health Improvement Network (THIN) for the study of psoriasis.Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.Attributable risk estimate of severe psoriasis on major cardiovascular eventsPsoriasis and vascular disease-risk factors and outcomes: a systematic review of the literatureSystemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot studyPrevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom.Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm MeetingChronic, not acute, skin-specific inflammation promotes thrombosis in psoriasis murine modelsConcomitant Sleep Disorders Significantly Increase the Risk of Cardiovascular Disease in Patients with PsoriasisPsoriasis and Cardiovascular Risk: Strength in Numbers Part 3Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic UseDisease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.Chronic skin-specific inflammation promotes vascular inflammation and thrombosis.Psoriasis and cardiovascular risk: strength in numbers, part II.Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational StudyComparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.Survival analysis using primary care electronic health record data: A systematic review of the literature.Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study.Transcriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis.
P2860
Q21135505-5A09ECDA-BD40-4EAD-A8B0-3D5FBD0F3EB5Q24629796-B6ED65E7-6EE6-4E46-B083-3D76EE4AAA2DQ26747639-9A49D4FE-26C7-459F-9D00-80431D90F07EQ30248952-A05ABBFD-7711-449F-84B8-587EC09A72EDQ30250110-3E78FF43-4965-4CEE-9B45-5D829539F493Q33694555-FED85D0B-970E-4D6E-877C-30794B7BF0DEQ33706485-B77BA762-90E5-4D56-ADFB-B044F3FD8D35Q33823950-49D61322-5706-4CE2-9B23-487E623DC31EQ33831065-DD403984-8DD2-4A28-9703-EA38375074CDQ33835705-34B87670-96CA-4362-AF1D-46F13A8C15E9Q33940511-B163FB79-7A67-4B7E-ACE4-7951898D699EQ33951592-41E724BA-8716-4450-B457-23D129B9CCA2Q34194956-B0DFDB8D-B15D-44E5-BBF5-7B448B1FFCF9Q34253312-42159129-F10A-4828-A7A7-00B6D1CB6613Q34285159-D7264431-C3F3-446F-AD13-580FBA6EA88FQ34356844-F72CA645-0E75-4338-9EA0-53A3EEA6C54FQ34364602-9CF561D6-A396-4735-A2EE-ADA7425CAAADQ34381490-90BDE0D6-36FF-4CB3-851B-CD909D251BA1Q34420240-EA56739D-50C0-4E6A-AA28-0F3625786AB3Q34434622-40B5110D-72A6-434A-980E-E3D29DDE5129Q34721703-135B6DF6-DD80-4649-B864-DD81172D7B05Q34812877-BE4BF32A-65A9-4F6C-8005-505FBA3D242EQ35124825-BD0A5A09-6FD0-4930-91D8-E31D6B660275Q35135113-38578118-D594-4714-BEE4-5DAD3AEE326FQ35168945-FA4A250E-CB11-4615-A795-43B923ADFF4AQ35171276-3BE7E6FB-EAF1-4AE9-B6AF-F17C044AF9C7Q35753936-7B055988-45E6-4172-8935-22035032F629Q35822379-4C6810C0-3F67-4BA7-B598-622B792D2089Q35870923-51EFE083-667C-4B0F-8606-824A3F911FB1Q35888911-12A45AF3-840A-4805-8DAA-86846E368C88Q35962417-2468F5C9-7D08-47A2-A045-5C7DBB5880CDQ35996755-703D58C8-A0D5-4EAA-8E6C-821A69DF9D94Q36083240-A2074A6E-D0B9-4816-A0BE-6DDAF135D694Q36110025-8B5F5CB1-0EC0-4FBF-B6D4-4854BD2DECD2Q36185077-5365087B-3D3F-407D-87CB-712495A9D5BAQ36326833-CED41111-B63C-4156-A0F9-6866EB078B5EQ36334747-0B636352-C366-4675-84D6-8ECB8C98FC4AQ36379016-3E6DAAF6-5492-403E-9FFC-4083E3803E2EQ36404574-F95DBE4B-3215-4BEF-A83E-411117DF2A06Q36500064-28DAA5C4-3DD5-45CD-AA69-0C22A4D025A8
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The risk of stroke in patients with psoriasis
@ast
The risk of stroke in patients with psoriasis
@en
type
label
The risk of stroke in patients with psoriasis
@ast
The risk of stroke in patients with psoriasis
@en
prefLabel
The risk of stroke in patients with psoriasis
@ast
The risk of stroke in patients with psoriasis
@en
P2093
P2860
P50
P356
P1476
The risk of stroke in patients with psoriasis
@en
P2093
Daniel B Shin
Rahat S Azfar
Shanu K Kurd
Xingmei Wang
P2860
P2888
P304
P356
10.1038/JID.2009.112
P407
P577
2009-05-21T00:00:00Z
P5875
P6179
1018232639